Loading clinical trials...
Loading clinical trials...
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent and clinically meaningful side effect of cancer treatment. It is induced by neurotoxic chemotherapeutic agents, causing severe s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Basel
Collaborators
NCT06389721 · Chemotherapy-induced Peripheral Neuropathy
NCT05840562 · Chemotherapy-induced Peripheral Neuropathy
NCT07072468 · Chemotherapy-induced Peripheral Neuropathy, Drug-Induced Nephropathy
NCT06769061 · Gynaecological, Urological or Rectal Cancer, Chemotherapy-Induced Peripheral Neuropathy, and more
NCT06162403 · Peripheral Nerve Stimulation, Chemotherapy-induced Peripheral Neuropathy
University of Basel
Basel
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions